论文部分内容阅读
目的观察瑞舒伐他汀治疗高血压病合并高脂血症临床疗效。方法把182位高血压病合并高脂血症患者随机分为治疗组和对照组。对照组常规药物治疗,治疗组在常规治疗基础上加用瑞舒伐他汀10mg每晚1次,疗程8周。观察两组治疗前后血压、血脂变化等。结果与对照组相比,治疗组TC(3.6mmol/L比5.6mmol/L)、LDL-C(1.9mmol/L比3.3mmol/L)、SBP(127.5mm Hg比133.9mm Hg)、DBP(78.4比83.1mm Hg)均明显降低,未见明显肝肾、肌肉不良反应。结论瑞舒伐他汀治疗高血压病合并高脂血症疗效确切,安全可靠。
Objective To observe the clinical efficacy of rosuvastatin in the treatment of hypertension and hyperlipidemia. Methods 182 hypertensive patients with hyperlipidemia were randomly divided into treatment group and control group. Control group conventional drug treatment, the treatment group on the basis of conventional treatment with rosuvastatin 10mg 1 night, treatment for 8 weeks. Before and after treatment, blood pressure, blood lipids and other changes were observed. Results Compared with the control group, TC (3.6mmol / L vs 5.6mmol / L), LDL-C (1.9mmol / L vs 3.3mmol / L), SBP (127.5mm Hg vs 133.9mm Hg), DBP 78.4 than 83.1mm Hg) were significantly lower, no significant liver, kidney adverse reactions. Conclusion Rosuvastatin treatment of hypertension with hyperlipidemia is effective, safe and reliable.